IFNG and neoplasm: This reprogramming significantly increased the production of effector molecules such as CD25, IFN-γ, and TNF-α, and markedly improved the anti-tumor activity of antigen-specific CTLs and ROR1-targeting CAR T cells in syngeneic murine models of melanoma and pancreatic cancer (Luu et al., 2021).